Elanco Animal Health, Inc. (ELAN)
24.41
+0.44
(+1.84%)
USD |
NYSE |
Aug 24, 16:00
24.41
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Gross Profit Margin (Quarterly) : 48.17% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.17% |
| March 31, 2026 | 47.19% |
| December 31, 2025 | 39.34% |
| September 30, 2025 | 41.07% |
| June 30, 2025 | 46.49% |
| March 31, 2025 | 46.61% |
| December 31, 2024 | 38.14% |
| September 30, 2024 | 39.32% |
| June 30, 2024 | 47.13% |
| March 31, 2024 | 46.22% |
| December 31, 2023 | 36.81% |
| September 30, 2023 | 41.29% |
| June 30, 2023 | 46.07% |
| March 31, 2023 | 50.04% |
| December 31, 2022 | 41.50% |
| September 30, 2022 | 41.52% |
| June 30, 2022 | 47.49% |
| Date | Value |
|---|---|
| March 31, 2022 | 47.31% |
| December 31, 2021 | 41.51% |
| September 30, 2021 | 43.15% |
| June 30, 2021 | 46.83% |
| March 31, 2021 | 42.35% |
| December 31, 2020 | 33.32% |
| September 30, 2020 | 39.59% |
| June 30, 2020 | 41.17% |
| March 31, 2020 | 41.57% |
| December 31, 2019 | 41.36% |
| September 30, 2019 | 46.70% |
| June 30, 2019 | 48.14% |
| March 31, 2019 | 46.27% |
| December 31, 2018 | 42.12% |
| September 30, 2018 | 45.01% |
| June 30, 2018 | 37.56% |
| March 31, 2018 | 44.42% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Zoetis, Inc. | 71.47% |
| Eli Lilly & Co. | 85.78% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| EyePoint, Inc. | -36.09% |
| Amylyx Pharmaceuticals, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.00% |
| Return on Assets | -1.48% |
| Return on Invested Capital | -1.86% |
| Profit Margin (Quarterly) | 3.95% |
| Operating Margin (Quarterly) | 8.63% |
| Return on Net Operating Assets | -1.62% |